To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Mycobacterium tuberculosis transmembrane transport protein 3 (MmpL3)

Infectious disease

INDICATION: Tuberculosis

In vitro, cell culture and mouse studies identified a carboxamide-based MmpL3 inhibitor that could

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE